About UsProductsInvestor RelationsPress ReleasesContact Us
February 13, 2014

Merus Labs International Inc. Announces First Quarter Results for Fiscal 2014
December 30, 2013

Merus Labs International Inc. Announces Results for Fiscal 2013
September 24, 2013

Merus Labs International Inc. Announces Completion of Debt Refinancing
September 3, 2013

Merus to Present at 15th Annual Rodman & Renshaw Investment Conference
August 26, 2013

Merus Labs International Inc. Announces Factive Product Divestiture
ENABLEX®/ EMSELEX®
Enablex® (darifenacin) is a prescription medicine used in adults to treat the following symptoms of overactive bladder: a strong need to urinate with leaking or wetting accidents (urge urinary incontinence), a strong need to urinate right away (urgency), and having to urinate often (urinary frequency)... [more]
VANCOCIN® capsules
Clostridium difficile infection (CDI) causes watery or mucousy diarrhea, lower abdominal pain and systemic symptoms such as fever, anorexia, nausea and malaise when mildly symptomatic, and life-threatening toxic megacolon when severe... [more]

Symbol: MSLI
Last:
Change:
Date:
Time:
Symbol: MSL
Last:
Change:
Date:
Time:
Quotes are delayed at least 15 minutes.
Get latest news from Merus Labs via e-mail.
Subscribe
Unsubscribe
Submit

Copyright © 2012 Merus Labs Inc. All Rights Reserved.